Top Companies To Invest In 2014

[ July 30, 2013 | Author: Admin | Weather: | Mood: normal]

Last Friday, the SEC formally filed civil charges against Steven A. Cohen that could ultimately bar him from the financial industry. Today, the SEC scheduled Cohen’s hearing, which will take place Aug. 26 at the SEC’s D.C. headquarters, rather than a courtroom.

According to Bloomberg, the Wall Street billionaire has seen his SAC Capital Advisors group of hedge funds return a remarkable 25% per year since 1992, as Cohen himself was charging record 50% fees on the sizable profits each year.

The SEC isn’t actually charging Cohen himself with insider trading or securities fraud; it claims only that Cohen failed to supervise underlings as they engaged in what the SEC claims was blatant insider trading. This is the first time the SEC has gone after Cohen directly; SAC Capital, however, has had a tough year with regulators, ponying up more than $600 million — a record penalty — in March to settle a separate SEC case claiming SAC traded using privileged information.

Top Companies To Invest In 2014: Gold World Resources Inc (GDW.V)

Gold World Resources Inc., an exploration stage company, engages in the acquisition, exploration, development, and mining of mineral resource properties in Canada. The company primarily explores for gold and silver deposits. It holds a 100% interest in the Mount Anderson Yukon gold/silver, polymetallic project located in the Wheaton River District in Yukon, Canada. The company was formerly known as Strikezone Minerals (Canada) Ltd. and changed its name to Gold World Resources Inc. in January 2006. Gold World Resources Inc. was founded in 1981 and is headquartered in Toronto, Canada.

Top Companies To Invest In 2014: Challenger Financial Services Group(CGF.AX)

Challenger Financial Services Group Limited operates as an investment management firm in Australia. The company operates as an issuer of annuities and a provider of listed and unlisted investment products and services to institutional and retail clients. It also provides various investment choices across a range of asset classes and investment styles, as well as operates as an investment manager. The company was founded in 1985 and is based in Sydney, Australia.

10 Best Stocks For 2014: Hays(HAS.L)

Hays plc operates as a specialist recruitment company. It provides temporary and permanent placement recruitment services, including qualified, professional, and skilled recruitment to public- and private-sector markets. The company specializes in various areas, including accountancy and finance, construction and property, information technology, life sciences, sales and marketing, banking and capital markets, contact centers, education, engineering and manufacturing, executive, financial services, health and social care, human resources, legal, energy, oil and gas, office professionals, retail, purchasing, resources and mining, and telecom industries. It has operations in the United Kingdom, the Asia Pacific, continental Europe, and Latin America. Hays plc is based in London, the United Kingdom.

Top Companies To Invest In 2014: Windarra Minerals Ltd (WRA.V)

Windarra Minerals Ltd. engages in the acquisition and exploration of mineral properties in Canada. It primarily explores for gold deposits. The company holds a 100% interest in the Mishi Leases property, as well as a 25% interest in certain claims in the Magnacon East Property located in the Sault Ste. Marie Mining division, Ontario. It also owns interests in the Pukaskwa property that consists of 55 contiguous unpatented mining claims located 50 kilometers west of Wawa, Ontario; and a 70% interest in the Little Deer Lake property in northern Saskatchewan. The company was formerly known as Minas de Cerro Dorado Ltd. and changed its name to Windarra Minerals Ltd. in 1979. Windarra Minerals Ltd. was founded in 1972 and is headquartered in Vancouver, Canada.

Top Companies To Invest In 2014: 3SBio Inc.(SSRX)

3SBio Inc., a biotechnology company, engages in the research, development, manufacture, and distribution of pharmaceutical products in the People?s Republic of China. Its products include EPIAO, an injectable recombinant human erythropoietin to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions; and TPIAO, a recombinant human thrombopoietin to treat chemotherapy-induced thrombocytopenia. The company also offers Intefen, a recombinant interferon alpha-2a product for the treatment of carcinoma of the lymphatic or hematopoietic system and viral infectious diseases; Inleusin, a recombinant human IL-2 product to treat renal cell carcinoma, metastatic melanoma, and thoratic fluid build-up caused by cancer and tuberculosis; and Iron Sucrose Supplement for treating anemia associated with iron deficiency, as well as for patients with end-stage renal disease requiring iron replacement therapy. In addition, its product pi peline comprises a high dosage EPIAO; NuPIAO, a second-generation EPIAO; TPIAO to treat idiopathic thrombocytopenic purpura; NuLeusin for metastatic melanoma and metastatic renal cell carcinoma; human papilloma virus vaccine for the prevention of cervical cancer; and an anti-TNF monoclonal antibody product candidate for treating rheumatoid arthritis, psoriasis, and other inflammatory diseases. Further, the company?s product pipeline includes Feraheme, an in-licensed intravenous iron replacement therapeutic agent used to treat iron deficiency anemia in chronic kidney disease patients and in patients requiring hemodialysis; and Nephoxil, an iron-based phosphate binder for the treatment of hyperphosphatemia in patients with ESRD. It sells its products directly, as well as through its network of distributors to various healthcare providers, including hospitals, clinics, and dialysis centers. The company was founded in 1993 and is headquartered in Shenyang, the People?s Republic of China.

Advisors’ Opinion:

  • [By Hilary Kramer]

    3SBio (NASDAQ:SSRX) is based in China, so it has suffered from the uncertainties that have hit the stock market there, but it’s a solid company that should achieve strong growth for years to come. The majority of sales come from two strong products, EPIAO and TPIAO, which have both benefited from improved regulations and access in China. 3SBio should increase revenues in excess of 20% over the next two years, but the stock is attractively valued at only 12 times the 2012 estimate of 95 cents a share. SSRX is an attractive buy at current prices.

Comments are closed.